Il 2 Sucks Customer Reviews and Feedback
The Ilyushin Il-2 (Cyrillic: Илью́шин Ил-2) Shturmovik (Cyrillic: Штурмови́к, Shturmovík) was a ground-attack aircraft produced by the Soviet Union in large numbers during the Second World War. With 36,183 units of the Il-2 produced during the war, and in combination with its successor, the Ilyushin Il-10, a total of 42,330 were built, making it the single most produced military aircraft design in aviation history, as well as one of the most produced, piloted aircraft in history along with the American postwar civilian Cessna 172 and the Soviet Union's own then-contemporary Polikarpov Po-2 Kukuruznik multipurpose biplane.
North Korea carrier Air Koryo seeks to update fleet with Russian airliners and extend flights to 'Axis of Evil' states is an article posted on flightglobal.com, "Russia's principal lessor Ilyushin-Finance (IFC) says it is interested in supplying Il-96s and Tu-204s to North Korea on standard 15-year financial lease terms modelled on the Il-96-300VIP deal agreed with Cuban flag carrier Cubana. IFC says initial contacts have taken place, but declines to comment on the status of talks with Air Koryo. The Russian government provides guarantees to state-run banks lending funds to IFC and Russian manufacturing plants for the production of Il-96s and Tu-204s for overseas customers. Air Koryo (formerly Chosonminhang) hopes that the lease-purchase of modern Russian jets will boost its passenger numbers and enable direct flights to Iran, another "rogue state" grouped with North Korea into the "Axis of Evil" by US president George Bush. Other Axis states (now diplomatically relabelled "outposts of tyranny") considered for trade links by North Korea's government include Belarus, Burma (Myanmar), Cuba, Syria and Zimbabwe."
Marketing Manager (Former Employee) says"This company preaches work/life balance but has none of their own. CEO is hotheaded and creates a stressful work environment. I was promoted from contract worker to employee but when each paycheck came along, the CEO "forgot" to take out the taxes leaving me as a contract worker while expecting me to hold employee responsibilities. They never reported that I worked for this company so when I reached out asking why I never received tax forms they kept coming up with different excuses as to why it was taking so long. Due to this lengthy process, I was unable to file in time to receive the COVID stimulus check. The concept of the company is great but working here is not worth it."
Licensed Veterinary Technician (Former Employee) says"Constant computer program issues. Very unprofessional. Very little to no training. They "throw you to the wolves" with very little support and expect perfection. You feel as if you don't have the adequate tools and information you need to help clients and their pets. Cons: Very sketchy payroll process"
Internship (Former Employee) says"zero office culture. Cold, abrasive management style. Be weary that even as an independent contractor you WILL be treated as an employee and can be terminated if you try and to dispute the chain of command. Never reported that I worked for the company making filing taxes and receiving unemployment nearly impossible."
Triage licensed veterinary technician (Former Employee) says"A fast growing company that is not keeping up with its growth. Cons: Overall disorganized"
Monsieur Queneau says"2/5 across the hillocks comes a steady blow The Papuan sucks his friend's apophyses the mob demands that verse be comme il faut"
Sheryl Bass says"#UberEats sucks!! I ordered delivery from them for #GreenPeapod in McHenry, Il and waited for 2 hours and the food… https://t.co/RdLWGogGIy"
Sue Diederich says"@dianevalead @BardsFM See - that sucks worse... To be in your field and STILL not be able to advance. Mom had a tea… https://t.co/Mgxl16P6c7"
~0~ #VoteBlueToSaveAmerica says"RT @Joelsherman1: The #Yankees have scored 12 runs and sent 19 players to the plate between the 2nd and 3rd innings — Giancarlo Stanton is…"
In The News
FierceBiotech reports"Simcha debuts with $25M to advance custom-built IL-18 for cancer"
PipelineReview.com reports"Neoleukin Therapeutics Presents Preclinical Data for NL-201 and De Novo Protein Design Technology at American Association for Cancer Research (AACR) Virtual Annual Meeting II | Proteins and Peptides | News Channels"
PRNewswire reports"Alkermes Announces Publication of Preclinical Data for ALKS 4230 in the Journal for ImmunoTherapy of Cancer"
Endpoints News reports"Computational scientists design a new IL-2 cancer drug and spin it out into a biotech startup"